A5006842840- Salivary Gland Disorders and Functions
- Salivary Gland Tumors Diagnosis and Treatment
- Systemic Sclerosis and Related Diseases
- Galectins and Cancer Biology
- Oral Health Pathology and Treatment
- Autoimmune Bullous Skin Diseases
- Otitis Media and Relapsing Polychondritis
- COVID-19 Pandemic Impacts
- Lymphoma Diagnosis and Treatment
- Myasthenia Gravis and Thymoma
- Growth Hormone and Insulin-like Growth Factors
- Diabetes and associated disorders
- Systemic Lupus Erythematosus Research
- Employment and Welfare Studies
- Latin American socio-political dynamics
- Cutaneous lymphoproliferative disorders research
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Hospital Británico de Buenos Aires
2014-2021
Icesi University
2021
Center for Rheumatology
2016
Hospital Británico
2013-2015
Argentine Water and Sanitation (Argentina)
2013
Primary Sjögren syndrome (pSS) is a chronic autoimmune disease with its main target being exocrine glands, and the connective tissue more frequently associated other diseases. The aim of this study was to assess frequency another rheumatic (ARD) developed in primary patients describe it's clinical, serological histologic characteristics.This retrospective cohort study. Data pSS diagnosis (American-European criteria 2002), included GESSAR database (Grupo de Estudio Síndrome Sjögren, Sociedad...
<h3>Background:</h3> Primary Sjogren´s syndrome (pSS) is an autoimmune disease that presents systemic manifestations one of the most significant tehe involvement peripheral nervous system. It may appear as onset SSp, although severe forms occur a late manifestation. <h3>Objectives:</h3> Describe frequency patients with pSS debuting PNS and those developing it during follow-up. Compare progression between this without, versus follow up. <h3>Methods:</h3> Observational, analytical, multicenter...
<h3>Background</h3> There is not enough evidence either to support the use of immunosuppressive drugs in pSS or for which specific clinical features they would be indicated. <h3>Objectives</h3> To evaluate most frequently prescribed and describe that determined indication,in a multicentric cohort Argentinean patients with pSS. analyze characteristics therapy comparison had received it. <h3>Methods</h3> We analyzed subjects included data-base Argentine study group SS (GESSAR). considered...
Background: Lymphoma is the main complication of primary Sjogren syndrome (pSS). The aim this study was to describe prevalence and incidence rate lymphoma in patients with pSS eleven centers Argentina. To determine frequency commitment domains baseline clinical ESSDAI who developed course their follow-up compare it rest sample. Methods findings: We included older than 18 years a diagnosis according American College Rheumatology/European League against Rheumatism (ACR/EULAR)2002/2016...
<h3>Background</h3> Interstitial lung disease (ILD) in primary Sjögren Syndrome (pSS) includes Non Specific Pneumonia (NSIP), Usual (UIP), Lymphocytic interstitial pneumonia (LIP) and Organized (OP), all related to poor outcome. The existing frequency of ILD is unknown Argentina. <h3>Objectives</h3> To describe the pSS using Argentinean Group Study for (GESSAR) database identify associated features disease. <h3>Methods</h3> GESSAR included 374 patients who fulfilled 2002 criteria pSS....
<h3>Background</h3> the clinical significance of hypocomplementaemia in primary Söjgren Syndrome (SSp) is being studied due to recent studies that associated low complement levels with lymphoma development and mortality. <h3>Objectives</h3> 1-To determine whether patients SSp (C3 and/or C4) at diagnosis have an increased frequency manifestations (at least one following: parotid swelling, arthritis, Raynaud, purple, lung parenchymal involvement, renal impairment, neuropathy lymphoma) compared...
<h3>Background</h3> The diversity of classification criteria for Primary Sjögren9s Syndrome (pSS) makes it difficult to draw conclusions from clinical studies. most commonly used are the 2002 American European criteria. Recently, new 2012 preliminary have been proposed. <h3>Objectives</h3> To assess diagnostic value both pSS criteria, American-European and 2012. <h3>Methods</h3> medical expert opinion rheumatologists different reference centers in Argentina was considered as Gold Standard....
<h3>Background</h3> The continuous overexpression of B lymphocytes in Primary Sjögren9s syndrome (pSS) produces a variety autoantibodies, like anti-Ro/SS-A or anti-La/SS-B, required for the diagnosis, albeit others pose an uncertain clinical significance. According to recent data, anti-α-fodrin antibodies could be used as reliable diagnostic marker those patients seronegative other antibodies. <h3>Objectives</h3> Thus, aim was determine frequency withpSS and describe their association....
<h3>Background</h3> Peripheral neuropathy (PN) is usually a late onset event in primary Sjögren Syndrome (pSS) associated with purpura, cryoglobulinemia, hypocomplementemia and increased risk of lymphoma. <h3>Objectives</h3> To describe the frequency PN patients pSS identify related factors. <h3>Methods</h3> Adult GESSAR database who met 2002 criteria for pSS. Demographic, clinical, laboratory electromyogram (EMG) findings were recorded. was defined clinic manifestations EMG. Other causes...
<h3>Background</h3> Sjögren9s syndrome (SS) is an autoimmune disease associated with focal lymphocytic infiltration in the epithelium of exocrine glands, and may develop systemic manifestations about 80% patients. Typical antibodies present SS are antinuclear antibody (ANA), rheumatoid factor, SSA/Ro SSB/La. classification criteria includes SSB/La, their presence extra-glandular manifestations. The prevalence 30–70%, related to increased frequency dermatologic symptoms, scleritis...
<h3>Objectives</h3> 1-Describe the frequency of clinical manifestations. 2- Assess their association with antibodies anti Ro/La, ANA, Rheumatoid Factor (RF) in patients Primary Sjögren's Syndrome (pSS). <h3>Methods</h3> It was analyzed information from GESSAR's (Argentine Group Study) database diagnosed pSS according to 2002 American-European criteria. <h3>Results</h3> Out 334 patients, 96% were women, a median age 57 (riq: 45-66), at time diagnosis 52 39-61) and onset symptoms 47 34-57),...
<h3>Objectives</h3> To compare histological and serological features clinical manifestations of Primary Sjögren`s Syndrome (pSS) diagnosed at the elderly age to those an early age. <h3>Methods</h3> It was analyzed GESSAR's (Argentine Study Group Sjögren's Syndrome) data base patients with pSS according 2002 American-European criteria, older than 18 years used chi-square test or Fisher's exact for categorical variables, expected frequency distribution table. performed a logistic regression...
Objective: to describe and compare the clinical manifestations, in adult patients diagnosed with primary Sjögren’s Syndrome at age less than or equal 35 years versus those over of age. Materials Methods: we analyzed data older 18 years, diagnosis syndrome (American-European criteria 2002), included GESSAR database (Sjögren Study Group Argentine Society Rheumatology). Results: 665 were included. One hundred them an a mean 29 + 4 92% women. The average group was 54 11 96% Statistically...
El objetivo de este artículo es considerar cómo la situación vulnerabilidad los y las trabajadoras informales ciudad Cali se ha reflejado en pandemia. Para esto tiene cuenta perspectiva Robert Castel, pues según el autor situaciones pueden devenir o contener dinámicas exclusión social. Así, toman como componentes esas contradicciones inherentes a afiliación desafiliación sistemas salud pensión.